Evidence map›Paper›PMID 35168715›Full record

ReviewInfectious disease clinics of North America2022

Management and Prevention of Staphylococcus aureus Infections in Children.

Ibukunoluwa C Kalu, Carol M Kao, Stephanie A Fritz

Open access · greenAbstract readReview
In one paragraph

Review in Infectious disease clinics of North America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Retrospective Study onAntibiotics (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ibukunoluwa C KaluDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Pediatric Infection Prevention, Duke University Medical Center, 315 Trent Drive, Hanes House #365, DUMC 3499, Durham, NC 27710, USA. Electronic address: https://twitter.com/SportsDoc2009.
Carol M KaoDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Washington University School of Medicine, 660 South Euclid Avenue, MSC 8116-43-10, St Louis, MO 63110, USA.
Stephanie A FritzDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Washington University School of Medicine, 660 South Euclid Avenue, MSC 8116-43-10, St Louis, MO 63110, USA. Electronic address: fritz.s@wustl.edu.
Washington University in St. Louis · USDuke Medical Center · US

Funding

SARS-CoV-2 Screening and Diagnostic testing for return to K-12 schoolsOT2HD107559 · NICHD · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K., ZIMMERMAN, KANECIA OBIE · 2021 to 2022
$5.0M
Integrating Personal and Household Environmental Hygiene Measures to Prevent Methicillin-Resistant Staphylococcus aureus InfectionR01HS024269 · AHRQ · WASHINGTON UNIVERSITY · PI FRITZ, STEPHANIE ANN · 2015 to 2019
$2.5M
AHRQ HHS R01 HS024269NICHD NIH HHS OT2 HD107559
6 · The paper itself

Abstract

Staphylococcus aureus is a common skin commensal with the potential to cause severe infections resulting in significant morbidity and mortality. Up to 30% of individuals are colonized with S aureus, though infection typically does not occur without skin barrier disruption. Infection management includes promptly addressing the source of infection, including sites of metastatic infection, and initiation of effective antibiotics, which should be selected based on local antibiotic susceptibility patterns. Given that S aureus colonization is a risk factor for infection, preventive strategies are aimed at optimizing hygiene measures and decolonization regimens for outpatients and critically ill children with prolonged hospitalizations.

Indexed as

Staphylococcal InfectionsStaphylococcus aureusAnti-Bacterial AgentsChildHumansOutpatientsRisk FactorsAnti-Bacterial AgentsBacteremiaColonizationDecolonizationMeningitisOsteomyelitisPneumoniaSkin infectionStaphylococcus aureus

Identifiers

PMID35168715
PMCPMC9901217
OpenAlexW4211023041

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.